No Data
No Data
The Hong Kong stock market is restructuring the value of pharmaceuticals! Hengrui Medicine has received a premium binding from AstraZeneca, and the stock price once rose over 20%.
① Does the offshore strategy mean that "technology platform premium + international certification" is replacing the traditional PE valuation method as the core logic for valuing Innovative Drugs companies? ② With JACOBIO-B narrowing its annual loss by 56.6% through its core product Galidesivir, can it be inferred that China’s Innovative Drugs companies have broken through the industry curse of "burning money on R&D - ongoing losses"?
How strong are the Hong Kong pharmaceutical stocks right now? The Innovative Drugs Index has risen over 30% this year, reaching a near 16-month high.
① The Innovative Drugs Index in the Hong Kong stock market has increased by over 30% this year; why can it compete with Technology stocks? ② There has been a "small peak" in the commercialization of individual stocks; how do Institutions perceive the future market direction?
SIHUAN PHARM (00460.HK) plans to hold a Board of Directors meeting on March 28 to approve the annual performance.
Gelonghui March 18丨SIHUAN PHARM (00460.HK) announced that the Board of Directors will hold a meeting on March 28, 2025 (Friday) to approve the performance of the company and its subsidiaries for the year ending December 31, 2024, and its release, as well as to discuss and approve (if applicable) the distribution of the final dividend.
SIHUAN PHARM: NOTICE OF BOARD MEETING
Is the CRO Concept "Return of the King"? WuXi AppTec aggressively attacks, leading stocks celebrate after performance!
Release the signal?!
GTJA: Continuous iteration of anti-tumor therapies, domestic new drugs welcome breakthroughs.
GTJA focuses on products with significant differentiation advantages and leading companies in innovative segments.
Kimtan88 : Pro
投智者KT OP Kimtan88 : It's not... Cham..
Kimtan88 : Too chim, don’t understand haha
Kimtan88 : So you own this stocks?
投智者KT OP Kimtan88 : Ya.. I expect it up.
View more comments...